News
Mislabeled clopidogrel lot recalled, may contain simvastatin
April 21, 2020
International Laboratories has recalled one lot of clopidogrel tablets packaged in bottles of 30 tablets because it may contain simvastatin instead of clopidogrel.
News
ASE issues echocardiography guidance amid COVID-19 pandemic
April 21, 2020
The ASE urges careful consideration of whom, where, and how to image to reduce the risks of SARS-CoV-2 transmission among echocardiography providers.
![1]()
News
PCSK9 inhibitors unexpectedly link with lower VTE, aortic stenosis
April 21, 2020
Post hoc analyses of data from as many as 46,000 patients showed surprising links between PCSK9 inhibition and reduced rates of VTE and aortic stenosis.
News
Interim guidance for CPR in patients with COVID-19
April 20, 2020
Performing CPR on patients with COVID-19 raises unique challenges. Interim guidance suggests approaches to mitigate risk to patients and providers.
News
COVID-19: How intensive care cardiology can inform the response
April 17, 2020
Cardiologists recommend adaptive staffing, organizational structure, medical treatment, and regional care pathways in the context of COVID-19.
![1]()
News
HFpEF: Gender difference in sacubitril/valsartan response remains mystery
April 17, 2020
Why did women on sacubitril/valsartan get a 27% reduction in cardiovascular death and heart failure hospitalization, while the men got nothing?
![1]()
News
Protean manifestations of COVID-19: “Our ignorance is profound”
April 17, 2020
“Make sure they didn’t die in vain.”
News
Evidence suggests possible RAS-blocker benefit in COVID-19 patients
April 16, 2020
Animal findings and physiologic mechanisms suggest RAS system inhibitors may benefit COVID-19 patients, another reason not to stop these drugs.
News
No hydroxychloroquine benefit in small, randomized COVID-19 trial
April 16, 2020
Two experts caution that because of confounding, the trial is unable to answer convincingly the question of whether HCQ can benefit COVID-19 patients.
![1]()
Opinion
COVID-19 mythconceptions
April 16, 2020
We are in a position where we need to take in what we can and assess the best data available.
